0001062993-23-008770.txt : 20230405 0001062993-23-008770.hdr.sgml : 20230405 20230405162719 ACCESSION NUMBER: 0001062993-23-008770 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230403 FILED AS OF DATE: 20230405 DATE AS OF CHANGE: 20230405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Borges Luis CENTRAL INDEX KEY: 0001684015 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40498 FILM NUMBER: 23802911 MAIL ADDRESS: STREET 1: TWO CORPORATE DRIVE STREET 2: C/O FIVE PRIME THERAPEUTICS, INC. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Century Therapeutics, Inc. CENTRAL INDEX KEY: 0001850119 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 842040295 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3675 MARKET STREET CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: 215-981-4000 MAIL ADDRESS: STREET 1: 3675 MARKET STREET CITY: PHILADELPHIA STATE: PA ZIP: 19104 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0407 4 2023-04-03 0001850119 Century Therapeutics, Inc. IPSC 0001684015 Borges Luis 3675 MARKET STREET PHILADELPHIA PA 19104 0 1 0 0 Chief Scientific Officer 0 Common Stock 2023-04-03 4 M 0 7452 1.03 A 256535 D Stock Option (right to buy) 1.03 2023-04-03 4 M 0 7452 0 D 2029-07-17 Common Stock 7452 0 D As of the date hereof, these stock options are vested and currently exercisable. /s/ Michael Diem, Attorney-in-Fact 2023-04-05